Related Experiment Video
Updated: Aug 14, 2026

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
[Diastolic dysfunction in liver cirrhosis]
1Clinica Medica, Università Milano-Bicocca, Azienda Ospedaliera San Gerardo, Monza, Milán, Italia.
Insights
Cirrhotic cardiomyopathy, characterized by diastolic dysfunction, affects liver disease patients. Understanding this cardiac issue is crucial for managing liver cirrhosis complications and reducing cardiovascular risk.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Hyperdynamic circulation is a known complication of liver cirrhosis.
- Early studies suggested alcoholic cardiomyopathy, but recent research highlights broader cardiac dysfunction in post-viral cirrhosis.
- Neurohumoral hyperactivity and cardiodepressant substances contribute to cardiac changes in advanced liver disease.
Purpose of the Study:
- To establish the clinical significance of diastolic dysfunction in liver cirrhosis.
- To introduce and define the concept of "cirrhotic cardiomyopathy".
- To improve understanding of cardiovascular risks associated with liver cirrhosis management.
Main Methods:
- Echocardiography used to detect left ventricular diastolic dysfunction and altered transmitral flow patterns.
- Review of existing studies on cardiac function in cirrhotic patients.
- Clinical observation of diastolic dysfunction, especially in decompensated cirrhosis.
Main Results:
- Clinically insignificant diastolic cardiac function has been observed.
- Lack of left ventricular relaxation and altered transmitral flow are characteristic findings.
- Growing evidence points to diastolic dysfunction as a significant issue in liver cirrhosis.
Conclusions:
- Cirrhotic cardiomyopathy is a clinically relevant entity in liver cirrhosis.
- Understanding cirrhotic cardiomyopathy can help mitigate cardiovascular risks during procedures like paracentesis and liver transplantation.
- Further research into cirrhotic cardiomyopathy is needed to improve patient outcomes.
Abstract:
The presence of a hyperdynamic circulation in cirrhotic liver is currently a well established concept. The first studies of cardiac function in patients with cirrhosis suggested the existence of an alcoholic cardiomyopathy. More recently, altered left ventricular response to physiological and/or pharmacological stimuli in patients with post-viral liver cirrhosis has been established, and clinically insignificant diastolic cardiac function has also been observed. Neurohumoral hyperactivity and hyperdynamic circulation, which are associated with chronic exposure to the cardiodepressant substances present in advanced liver disease, play a decisive role in the genesis of this process. The lack of relaxation of the left ventricle and alteration in the pattern of transmitral flow, both of which are characteristics of this clinical entity, are easily detected by echocardiography. The growing evidence of diastolic dysfunction in liver cirrhosis, particularly in decompensated cirrhosis, suggests the clinical importance of the problem, thus introducing the concept of "cirrhotic cardiomyopathy". Greater insight into this phenomenon could help to decrease cardiovascular risk, especially during maneuvers commonly used in the treatment of the complications of liver cirrhosis, such as paracentesis, transjugular intrahepatic portosystemic shunt stent implantation, and liver transplantation.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Portal Hypertension
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
